Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

ABSTRACT:

Introduction

Diffuse intrinsic pontine glioma (DIPG) is a rare clinically, neuro-radiologically, and molecularly defined malignancy of the brainstem with a median overall survival of approximately 11 months. Our aim is to evaluate the current tendency for its treatment in Europe in order to develop (inter)national consensus guidelines.

Methods

Healthcare professionals specialized in DIPG were asked to fill in an online survey with questions regarding usual treatment strategies at diagnosis and at disease progression in their countries and/or their centers, respectively.

Results

Seventy-four healthcare professionals responded to the survey, of which 87.8% were pediatric oncologists. Only 13.5% of the respondents biopsy all of their patients, 41.9% biopsy their patients

SUBMITTER: El-Khouly FE 

PROVIDER: S-EPMC6775536 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature